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Abstract 
Cerebral autoregulation (CA) dampens transfer of blood pressure (BP)-fluctuations onto cerebral 
blood flow velocity (CBFV). Thus, CBFV-oscillations precede BP-oscillations. The phase angle 
(PA) between sympathetically mediated low-frequency (LF: 0.03-0.15 Hz) BP- and CBFV-
oscillations is a measure of CA quality. To evaluate whether PA depends on sympathetic 
modulation, we assessed PA-changes upon sympathetic stimulation with and without 
pharmacologic sympathetic blockade. 
In 10 healthy, young men, we monitored mean BP and CBFV before and during 120-seconds cold 
pressor stimulation (CPS) of one foot (0°C ice-water). We calculated mean values, standard 
deviations and sympathetic LF-powers of all signals, and PAs between LF-BP- and LF–CBFV-
oscillations. We repeated measurements after ingestion of the adrenoceptor-blocker carvedilol (25 
mg). We compared parameters before and during CPS, without and after carvedilol (analysis of 
variance, post-hoc t-tests, significance: p<0.05). 
Without carvedilol, CPS increased BP, CBFV, LF-BP- and LF-CBFV-powers, and shortened PA. 
Carvedilol decreased resting BP, CBFV, BP-LF- and CBFV-LF-powers, while PAs remained 
unchanged. During CPS, BPs, CBFVs, BP-LF- and CBFV-LF-powers were lower, while PAs were 
longer with than without carvedilol. With carvedilol, CPS no longer shortened resting PA. 
Sympathetic activation shortens PA. Partial adrenoceptor blockade abolishes this PA-shortening. 
Thus, PA-measurements provide a subtle marker of sympathetic influences on CA and might refine 
CA evaluation. 
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Abbreviations 
CA:  cerebral autoregulation 
BP:  blood pressure 
CBFV: cerebral blood flow velocity 
CPS:  cold pressor stimulation 
ETCO2:  end-tidal carbon dioxide levels 
HF:  high-frequency 
LF:  low-frequency 
PA:  phase angle 
RRI:  RR-interval 
SD:   standard deviation 
TCD:  transcranial Doppler sonography 
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1. Introduction 
Cerebral autoregulation (CA) assures constant cerebral blood flow in the face of changing blood 
pressure (BP) [1, 2], and is altered in neurovascular disorders [3-7]. Under physiologic conditions, 
various components, such as myogenic, endothelial and neurogenic, primarily sympathetic 
mechanisms, contribute to dampening the transfer of BP fluctuations onto CBFV [8-10].  
While there is controversy regarding the autonomic contribution to static cerebral autoregulation, 
operating over several minutes [2, 11-14], there is increasing evidence that sympathetic innervation 
contributes to the dynamic component of cerebral autoregulation, i.e. to the mechanisms 
maintaining stable cerebral blood flow in response to transient blood pressure changes that occur 
within several seconds, e.g. upon standing-up [15-19]. 
To ascertain stable cerebral perfusion, autoregulation buffers the effects of BP changes onto CBFV 
and keeps CBFV fluctuations significantly smaller than BP fluctuations [1, 20, 21].  
The CA dynamics can be compared with a high-pass filter, which dampens slow BP changes more 
prominently than rapid BP perturbations [10, 16, 20, 22, 23]. Since the buffering effects of CA are 
frequency-dependent, CA quality can be evaluated by comparing BP and CBFV oscillations in the 
frequency domain [10, 16, 20, 22, 23]. 
The high-pass filter characteristics of autoregulation shift CBFV-oscillations to the left of 
corresponding BP-oscillations [20, 22, 24-26]. Therefore, buffered maxima or minima of CBFV-
oscillations occur prior to maxima or minima of corresponding BP-oscillations [1, 20, 22]. 
The shift between “leading” CBFV-oscillations and “lagging” BP-oscillations [1, 20, 22] can be 
reliably assessed as phase angle (PA) between sinusoidal, sympathetically mediated BP- and 
CBFV-oscillations that occur in the so-called low frequency (LF) range from 0.03 to 0.15 Hz [1, 10, 
16, 20, 27, 28]. PA between coherent LF-oscillations of BP and CBFV constitutes a valid 
measurement tool of CA [1, 10, 20, 22, 29-31].  Normally, PA between LF-oscillations of BP and 
CBFV ranges from -30° to -90° [1, 22, 29, 31, 32]. However, cerebrovascular pathology, for 
example cerebrovascular stenosis [22] or cerebral angiopathy with progressive intracranial artery 
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stiffening [30], is associated with compromised CA and causes PA reduction due to impaired 
dampening of BP fluctuations and a more passively driven change in CBFV that follows changes in 
BP [22, 31]. 
However, even in healthy persons, the change in body position from supine to standing decreases 
the PA between LF-oscillations of BP and CBFV [29]. Cencetti and co-workers therefore assumed 
that an increase in sympathetic activity as induced e.g. during standing-up can decrease PA [29]. 
During phenylephrine-induced BP increases, Zhang et al. also found PA decreases associated with 
increased cerebrovascular resistance [17].  
Improved understanding of mechanisms underlying PA-changes promises clinical relevance for a 
refined assessment of cerebrovascular diseases, particularly diseases with altered sympathetic 
activity, e.g. subarachnoid hemorrhages [10, 33-37]. 
Since BP- and CBFV-oscillations in the LF-range are associated with sympathetic activity [10, 20, 
38, 39], we hypothesize that changes in the PA between coherent LF-oscillations of BP and CBFV 
are also related to changes in sympathetic activity. 
To evaluate this hypothesis, we tested whether the PA between LF-BP- and LF-CBFV-oscillations 
decreases with sympathetic stimulation and - if so - whether such PA-decrease attenuates upon 
partial pharmacologic sympathetic blockade. 
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2. Material and Methods 
2.1. Subjects 
Ten healthy men (mean age 25±2 years) participated in the study. No participant had any disease or 
took medication affecting the cardiovascular or autonomic nervous system. Before testing, 
participants underwent physical examination (Wasmeier G), duplex sonography of the extracranial 
carotid and vertebral arteries to rule out vascular pathologies, a 12-lead electrocardiogram and an 
echocardiogram ruling out cardiac abnormalities. Transcranial Doppler sonography (TCD) at the 
temporal and suboccipital windows confirmed normal intracranial CBFVs of the vertebral, basilar, 
middle, posterior, and anterior cerebral arteries [10]. 
 
2.2. Procedures 
Studies were performed in a quiet room with 24°C ambient temperature and stable humidity. 
Initially, participants rested in supine position for 45 minutes to ensure cardiovascular stability 
while monitoring devices were applied [10]. 
For 5 minutes at rest and during 120-second cold pressor stimulation (CPS, see below), we 
continuously recorded electrocardiographic RR-intervals (RRI) using a 5-lead ECG. We non-
invasively monitored mean arterial BP by radial artery-tonometry with calibration at the brachial 
artery [8]. End-tidal carbon dioxide levels (ETCO2) were monitored using infrared spectrometry via 
nasal cannulae (Colin Pilot, San Antonio, TX). Mean CBFV of the proximal middle cerebral artery 
(MCA) was assessed by 2 MHz transcranial Doppler sonography (TCD; Multidop XL, DWL, 
Germany) through the temporal window, approximately 1 cm above the zygomatic arch at a depth 
of 35 to 55 mm. The Doppler probe was attached to the skull at a fixed angle using a headband with 
adjustable positioning system. Respiratory frequency was monitored by inductance 
plethysmography using 2 calibrated belts attached around the thorax and abdomen (Respitrace 
Calibrator, Ambulatory Monitoring Inc., Ardsley, NY) [8, 10].  
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From 60-second intervals at rest and during the last 60 seconds of the 120-second CPS, we 
calculated mean values and standard deviation of all bio-signals.  
 
2.3  Data acquisition and analysis 
Data were digitized by a custom-made analogue-to-digital converter at a sampling rate of 300 Hz 
and fed to a Macintosh PowerBook computer (Apple Inc.), manually cleaned from artifacts by 
linear interpolation and stored for offline analysis [40]. A C-language program identified all 
electrocardiographic QRS-complexes in each sequence, located the peak of each R-wave and 
calculated consecutive RRIs. From the continuous waveforms of all parameters, beat-to-beat mean 
values were calculated and interpolated linearly between adjacent values to construct a 
corresponding continuous time series [40].  
RRI-, BP- and CBFV-values show underlying fluctuations that are largely mediated by undulating 
activity of the sympathetic and parasympathetic nervous systems [20]. These underlying 
fluctuations were characterized by autoregressive analysis using a linear detrending option and 
model order estimation according to Akaike information criteria [41]. The autoregressive algorithm 
reliably estimates the frequencies and powers of the relevant oscillations within a single segment 
based on a relatively small amount of data that still assures signal-stationarity [40]. To meet 
requirements of signal-stationarity, we maintained a 45 min. resting period and performed 
autoregressive bivariate analysis with an adequate model order of 12 which is suited for analysis of 
short-term data, e.g. of only 60 seconds, and allows for a better frequency resolution than simpler 
Fourier-based approaches [42, 43]. 
Parasympathetic, respiratory influences are considered to account for RRI-modulation in the so-
called high-frequency (HF-) range between 0.15 and 0.5 Hz, as parasympathetic modulation of 
RRIs is most pronounced at the frequency of respiration [20, 38]. Therefore, we used RRI-
modulation in the HF-range as index of parasympathetic modulation [20, 38]. In contrast, BP-
fluctuations in the HF-range are primarily a mechanical consequence of respiration-induced 
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increases in venous return and stroke volume [20, 38, 44]. While parasympathetic influences on 
RRI may still occur at frequencies below 0.15 Hz, BP- and CBFV-fluctuations in the so-called low-
frequency (LF-) range between 0.03 and 0.15 Hz are considered to be related to sympathetic 
outflow only [10, 20, 38]. Therefore, we determined the degree of sympathetic signal-modulation 
from the amount of LF-BP- and LF-CBFV-modulation [20, 38]. 
Sympathetic and parasympathetic influences on RRI-, BP- and CBFV-variability were assessed by 
quantifying the LF- and HF-components of the bio-signals. The magnitude of sympathetic or 
parasympathetic modulation was determined as integral under the power spectral density curves [8, 
20, 38]. 
Additionally, we calculated the PA between LF-oscillations in BP and CBFV reflecting the 
integrity of cerebral autoregulation (CA) [10, 30, 40, 43, 45] using the algorithm described by SLJ 
Marple [45] and applied in many previous studies assessing PA as a parameter of cerebral 
autoregulation [10, 24, 25, 29, 30, 40, 43, 46]. 
Dynamics of autoregulation can be compared with a high-pass filter [20, 22]. Rapid BP-
perturbations are transferred onto CBFV, whereas slow BP-changes below 0.07 Hz are dampened 
[10, 16, 22, 23]. As mentioned above, the relation between BP- and CBFV-oscillations can be 
described by calculating PA between the leading CBFV- and the lagging BP-signal [22].  
Coherence between BP- and CBFV-oscillations might span from 0 (no association) to 1 (maximal 
association) [40]. Two signals were considered to have a stable phase relation for a given frequency 
of oscillation if coherence was above 0.5 [40]. 
To calculate PAs at the most coherent frequency-peak within the LF range, we used the following 
formula [40]:    θ(f) = tan-1[Im{Φxy(f)} / Re{Φxy(f)}],  where θ(f) is the phase angle (PA), 
Im{Φxy(f)} and Re{Φxy(f)} represent the image and real part of the transfer function respectively 
[45]. 
 9 
Before and after pharmacological blockade (as described below), we assessed CPS-induced changes 
in PA between BP-oscillations and CBFV-oscillations in the LF-range, i.e. the frequency range that 
is considered to reflect oscillations mediated by sympathetic outflow [10, 47].  
 
2.4. Cold pressor stimulation (CPS) without and with partial sympathetic blockade 
To assess whether changes in the PA between sympathetically mediated LF-oscillations of BP and 
CBFV reflect changes in sympathetic influences on cerebral autoregulation, we used CPS as a 
stimulus that induces sympathetic activation [48, 49]. On two consecutive days, we evaluated CPS-
related changes in bio-signals and PA without and with partial sympathetic blockade using the 
alpha- and beta-adrenoceptor-blocker carvedilol. In one session, we tested CPS effects on RRIs, 
BPs and CBFVs and on LF- and HF-spectral powers of RRIs, BPs, and CBFVs without sympathetic 
blockade; in the other session we assessed CPS-effects two hours after participants had orally taken 
25 mg carvedilol in order to evaluate whether the alpha- and beta-adrenoceptor-blocker affects the 
recorded bio-signals and the PA between sympathetically mediated LF-oscillations in BP and 
CBFV. 
After the 45-minute resting-period, participants immersed one foot up to the ankles into ice-water 
with a temperature of 0-1 °C for 120 seconds. Since changes in carbon dioxide levels alter the 
diameter of cerebral vessels and thus cerebral blood flow velocity [2], participants were instructed 
not to hold their breath but to maintain their normal breathing pattern during the entire test. 
After the test, participants rated their level of discomfort or pain perception on a scale from 1 to 10 
with 1 as the lowest and 10 as the highest level of discomfort or pain [48]. 
 
2.5.  Statistical analysis 
We used the Kolmogorov-Smirnov test to test for normal distribution of data. Normally distributed 
data are presented as mean ± standard deviation (SD). Differences in cardiovascular parameters 
between measurements performed without and with pharmacologic blockade were evaluated by 
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analysis of variance for repeated measurements (ANOVA, general linear model), with “CPS” 
(before and during CPS) as first within subject factor and “blockade” (with and without 
pharmacologic blockade) as second within subject factor. Suitability of the ANOVA model was 
assessed by Mauchly's Test of Sphericity. In case of violation of the sphericity assumption, the 
Greenhouse-Geisser-correction was employed. In case of significant ANOVA results, post-hoc 
single comparisons were performed using t-test for paired groups and normally distributed data or 
the Wilcoxon-test in case of not normally distributed data. A commercially available statistical 
program (SPSS™, SPSS Inc., Chicago, Ill, USA) was used for data analysis. Significance was set at 
p<0.05 [10]. 
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3. Results 
Cold stimulation was perceived by all participants. On the 1 to 10 scale of discomfort and pain, 
participants indicated similar discomfort in the session without and the session with partial 
sympathetic blockade (7.4±1.3 vs. 6.9±0.7, p>0.05, Table 1).  
 
3.1. Cardio- and cerebrovascular responses to CPS without carvedilol medication 
Without carvedilol, CPS significantly accelerated heart rate, i.e. decreased RRIs (1018.8±164.8 vs. 
865.1±162.9 ms), and increased BP (83.7±7.3 vs. 98.3±11.3 mmHg) and CBFV (55.3±20.7 vs. 
62.6±22.1 cm s-1; p<0.05). ETCO2 remained unchanged (p>0.05). 
Moreover, CPS significantly increased LF-powers of RRIs (1338.1±1455.5 vs. 2546.1±2700.1 
ms2), of BP (4.0±3.6 vs. 7.4±7.9 mmHg2) and of CBFV (5.2±2.6 vs. 11.7±7.1 cm2 s-2) (p<0.05), but 
did not change HF-powers of RRIs, BP and CBFV (p>0.05). 
During CPS, PA between BP- and CBFV-oscillations in the LF-range was significantly smaller (-
34.3±18.3°) than PA at baseline, without stimulation (-53.0±20.1°, p<0.05, Table 1, Fig. 1). 
 
3.2. Effect of carvedilol medication on cardio- and cerebrovascular parameters at baseline  
At rest, carvedilol intake resulted in higher RRIs (1018.8±164.8 vs. 1110.9±177.9 ms), i.e. slower 
heart rates, and lower BPs (83.7±7.3 vs. 77.2±6.7 mmHg) and CBFVs (55.3±20.7 vs. 46.7±21.0 cm 
s-1) (p<0.05). ETCO2 at baseline was similar with and without carvedilol (p>0.05). 
Carvedilol also lowered resting LF-powers of RRIs (1338.1±1455.5 vs. 489.1±390.5 ms2), of BP 
(4.0±3.6 vs. 2.3±2.9 mmHg2) and of CBFV (5.2±2.6 vs. 3.3±1.6 cm2 s-2) (p<0.05), but did not 
change resting HF-powers of RRIs, BP and CBFV (p>0.05, Table 1).  
At rest, the PA between BP- and CBFV-oscillations in the LF-range was similar without (-
53.0±20.1°) and with carvedilol (-62.3±26.1°; Table 1), i.e. the carvedilol induced PA-increase was 
not significant (p>0.05, Fig. 1). 
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3.3. Effect of carvedilol on cardio- and cerebrovascular parameters during CPS 
With partial pharmacologic blockade, CPS still decreased RRIs (1110.9±177.9 vs. 1041.5±185.4 
ms), i.e. increased heart rate, and increased BP (77.2±6.7 vs. 88.2±11.1 mmHg) and CBFV 
(46.7±21.0 vs. 51.8±20.4 cm s-1) from baseline-values (p<0.05, Table 1). ETCO2 during CPS again 
was similar with and without carvedilol (p>0.05). 
However, during CPS, signal-values were higher with than without carvedilol for RRIs 
(1041.5±185.4 vs. 865.1±162.9 ms), and lower with than without carvedilol for BP (88.2±11.1 vs. 
98.3±11.3 mmHg) and CBFV (51.8±20.4 vs. 62.6±22.1 cm s-1, p<0.05, Table 1).  
Carvedilol also affected spectral powers of RRI, BP and CBFV. After carvedilol, CPS still 
increased LF-powers of RRIs (489.1±390.5 vs. 948.9±1055.9 ms2), BP (2.3±2.9 vs. 3.3±3.2 
mmHg2) and CBFV (3.3±1.6 vs. 5.8±3.4 cm2 s-2) from baseline-values (p<0.05, Table 1). However, 
during CPS, LF-powers were lower with than without carvedilol for RRI- (948.9±1055.9 vs. 
2546.1±2700.1 ms2), BP- (3.3±3.2 vs. 7.4±7.9 mmHg2) and CBFV- (5.8±3.4 vs. 11.7±7.1 cm2 s-2) 
oscillations (p<0.05). In contrast, neither carvedilol nor CPS changed HF-powers of RRIs, BP and 
CBFV (p>0.05, Table 1).  
During CPS, carvedilol increased or widened PA between LF-BP- and LF-CBFV-oscillations from 
-34.3±18.3° without sympathetic blockade to -57.0±23.8° with partial sympathetic blockade 
(p<0.05, Table 1). After blockade, there was no difference between the PA during CPS and the PA 
at rest (p>0.05, Table 1, Fig. 1). 
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4. Discussion 
Our data add to the increasing evidence that sympathetic innervation contributes to the dynamic 
component of cerebral autoregulation [15-19] and confirm our previous findings that 0.1 Hz CBFV 
oscillations are related to sympathetic modulation [10]. The results moreover show that the PA 
between sympathetically mediated LF-oscillations of BP and CBFV decreases with sympathetic 
activation, induced by cold pressor stimulation, and that partial sympathetic blockade completely 
abolishes the CPS-induced decrease in PA. 
At first sight, changes in PA, BP and CBFV from baseline values without sympathetic blockade to 
baseline values with blockade seem to suggest a discrepancy: Partial sympathetic blockade did not 
significantly change baseline PA values (-62.3±26.1°) from values without blockade (-53.0±20.1°; 
p>0.05) and thus indicated preserved autoregulation. In contrast, baseline values of BP (83.7±7.3 
mmHg) and CBFV (55.3±20.7 cm s-1) decreased significantly upon sympathetic blockade (to 
77.2±6.7 mmHg and to 46.7 ± 21.0 cm s-1 respectively). One might assume that the decrease in 
CBFV results from the BP decrease and thus indicates compromised cerebral autoregulation.  
However, several studies show 15% to 20 % changes in CBFV upon BP decreases during 
orthostasis [21, 25, 50-53] or ganglion blockade [15, 54] or in association with drug-induced BP 
increases [55], and demonstrate that CBFV changes may be discrepant or even diametrical to BP 
changes in healthy persons with intact cerebral autoregulation [21, 50, 51, 54].   
During increasing orthostatic challenge induced by increasing levels of lower body negative 
pressure (LBNP) stimulation, Levine and co-workers showed an increase in mean blood pressure 
(from 82±2 mmHg to 88±3 mmHg, mean ± SEM) but a decrease in CBFV by up to 15.5±5% [50].  
In 13 healthy persons aged 21 to 38 years, Immink et al. observed a significant increase in mean BP 
upon standing-up from 80±2 mmHg to 88±3 mmHg (mean ± SEM, p<0.05) while CBFV decreased 
significantly from 65.3±3.8 cm s-1 to 54.6±3.3 cm s-1, i.e. by 16.4% [51].  In healthy controls, aged 
23 to 51 years, Mahony et al. induced a 26.4±7.1 mmHg step-drop in mean BP by means of the 
thigh-cuff method, i.e. after release of 2 minute blood flow occlusion to the lower extremities, and 
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recorded a decrease in CBFV by 15.6±5.8 cm s-1 that preceded BP decrease by more than 2 seconds 
[56]  In 11 healthy controls, aged 24.1±0.6 years, Medow et al. induced a 10% increase in mean BP 
with intravenous phenylephrine infusion, and recorded a significant increase in CBFV by 10.6% 
(P<0.05) [55].  In 15 healthy persons, aged 30.7±1.7 years (mean ± SEM), Schondorf et al. recorded 
a significant increase in diastolic BP by 14.1±1.7 mmHg (p<0.0001) and a slight increase in systolic 
BP by 3.4±4.1 mmHg upon head-up tilt, while there was a significant decrease in systolic CBFV by 
-20.0±3.4 cm s-1 (p=0.0001) and in diastolic CBFV by -8.8±2.0 cm s-1 (p=0.0006) [21].  In one of 
our previous studies assessing LBNP effects in healthy persons and type II diabetic patients, we 
even saw that CBFV decreased in healthy persons from 47.4 ± 18.8 cm s-1 at baseline to 40.7 ± 13.3 
cm s-1   during -40mmHg LBNP although mean BP did not drop during -40mmHg LBNP 
stimulation  (92.0 ± 16.9 mmHg) but remained unchanged from baseline BP values (91.8 ± 12.7 
mmHg) [25].   In a study assessing cardio- and cerebrovascular responses to 180 seconds head-up 
tilt in patients with Familial Dysautonomia (i.e. Riley Day syndrome) and in healthy controls [53], 
our healthy participants showed a significant decrease in mean CBFV from 65.4 ± 8.9 cm s-1 to 58.6 
± 8.3 cm s-1 while mean BP did not drop but even slightly – though not significantly - increased 
from 72.3 ± 7.6mmHg to 77.0 ± 17.2 mmHg. 
Thus, the 15.6% decrease in CBFV seen in our study upon partial sympathetic blockade at rest is 
not necessarily a direct response to the 7.8% decrease in BP but might also reflect a response to the 
partial sympathetic blockade which seems to cause MCA dilatation - and thus CBFV slowing - at 
the insonated, proximal artery where the density of alpha-adrenergic sympathetic innervation is 
higher than at distal, small cerebral arteries [1, 9, 57-60]. 
The above mentioned variability of BP and CBFV changes upon orthostatic challenge [21, 25, 50, 
51, 53, 54], with no change or a decrease in one or both signals, or even diametrical changes, 
indicates that changes in CBFV within a limit of 15% to 20% are poorly suited to determine the 
quality of cerebral autoregulation. In contrast, the phase angle between 0.1 Hz sinusoid BP 
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oscillations and 0.1 Hz sinusoid CBFV oscillations proves to be a better suited parameter to assess 
the quality of cerebral autoregulation [10, 22, 24, 29, 30, 40, 43]. 
The 120-second cold pressor stimulation was sufficient to induce sympathetic activation as shown 
by the increases in heart rate (HR), BP [48, 61] and CBFV [62], and in the powers of 
sympathetically mediated LF-oscillations of RRI, BP and CBFV [10, 20, 38, 39]. 
The resulting PA-shortening might be ascribed to various mechanisms.One explanation may be the 
fact that higher LF-fluctuations of BP and CBFV during CPS are not buffered as early as are less 
pronounced LF-fluctuations recorded under baseline conditions [1, 9, 20, 22, 29, 31, 62]. 
Consequently, the PA between the leading LF-fluctuations of CBFV and the lagging LF-
fluctuations of BP is smaller during than before CPS [1, 20, 22]. 
Moreover, the CPS-induced BP increase itself might contribute to the PA shortening. Higher BP or 
pulse pressure augments the myogenic tone in large cerebral arteries and small cerebral arterioles 
[63] resulting in increased cerebrovascular resistance and decreased vascular compliance. The BP-
induced changes in visco-elastic properties of cerebral arteries may again alter CBFV-oscillations 
and in turn affect the PA [17]. “Stiffening” of intracerebral vessels caused by BP increases might 
shorten PA similar to the mechanisms that shorten PA in patients with intracranial arteriosclerotic 
stenosis [22].  
While the carvedilol-induced BP attenuation, i.e. the decrease in the input-signal of cerebral 
autoregulation, may also result in reduced myogenic autoregulatory responses, with less resistance 
and increased compliance of cerebral arteries [17], such direct effects of BP changes on PA seem to 
be minor. During head-up tilt, Cencetti et al. also saw shortening of the PA between LF-oscillations 
in CBFV and BP [29]. During orthostatic challenge, the authors observed a slight BP decrease but a 
significant increase in sympathetically mediated LF-BP- and LF-CBFV-oscillations [29].Therefore, 
the PA-shortening cannot be ascribed to any BP increase. Instead, Cencetti et al. assume that PA-
shortening reflects stiffening of intracerebral vessels induced by increased sympathetic activity [29]. 
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Moreover, changes recorded upon CPS–induced sympathetic activation but concurrent sympathetic 
blockade do not suggest a major direct contribution of BP to PA-changes. Despite carvedilol 
application, CPS still significantly increased BP from values prior to CPS. Thus, the 25mg 
carvedilol only induced a partial sympathetic blockade. Nevertheless, even such partial sympathetic 
blockade was sufficient to completely abolish PA-shortening during CPS (Table 1). 
Consequently, our data not only confirm the conclusion of Cencetti and co-workers that PA-
shortening during sympathetic challenge may be ascribed directly to increased sympathetic 
activation. The completely abolished PA response to even partial sympathetic blockade suggests 
that even gradual changes in sympathetic activity may alter PA. 
While Cencetti et al. presume that PA-shortening upon sympathetic activation is due to “stiffening” 
of distal cerebral vessels [29], we assume that there are opposing sympathetic effects on proximal, 
cerebral artery segments and on the distal cerebral arterioles.  
Sympathetic innervation is denser and primarily alpha-adrenergic at the proximal cerebral arteries 
than at the distal, primarily beta2-adrenergic cerebral arterioles [1, 9, 57-60]. Thus, the CPS 
associated CBFV increase and PA-shortening are likely to result from sympathetically mediated 
alpha-adrenergic vasoconstriction at the proximal MCA, i.e. at the site of our TCD-insonation, and 
from beta-adrenergic vasodilatation at distal cerebral resistance vessels [1, 10]. 
After carvedilol, the absence of CPS-induced PA-shortening very likely also results from diametric 
carvedilol effects on large, proximal and small, distal cerebral vessels. Carvedilol has a 2- to 3-
times higher selectivity for beta- than alpha-receptors [64]. Yet, the higher density of alpha-
adrenergic nerve terminals at proximal cerebral arteries and the lower density of predominantly 
beta-adrenergic nerve terminals at distal cerebral arterioles may outweigh the carvedilol specific 
differences in alpha- and beta-receptor selectivity [1, 9, 62]. Therefore, not only the CBFV increase 
and PA-shortening upon sympathetic activation seem to result from combined proximal 
vasoconstriction and distal vasodilatation of cerebral vessels. After carvedilol, the absent PA-
shortening and the attenuated CBFV increase during CPS also seem to result from partial blockade 
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of proximal vasoconstrictor and distal vasodilator activity. Mitigated proximal vasoconstriction as 
well as distal vasodilatation after carvedilol both explain the attenuated CBFV increase at the site of 
TCD-insonation during CPS [64].  
 
5. Conclusions 
Our data show that sympathetic stimulation shortens the PA between sympathetically mediated LF-
oscillations of CBFV and BP, while partial alpha- and beta-adrenergic blockade that is insufficient 
to fully block BP-increases during sympathetic stimulation still abolishes PA-shortening. 
We therefore conclude that shortening of the PA between LF-oscillations of CBFV and BP during 
sympathetic stimulation such as CPS may serve as a measure of sympathetic effects on the proximal 
and distal cerebral arteries. 
Assessing the PA between coherent BP- and CBFV-oscillations in the LF-range might be clinically 
relevant and could provide an early marker of altered cerebrovascular autoregulation [1, 20, 30, 31]. 
 
6. Study limitation 
One limitation of our study arises from the TCD technology that does not directly assess diameter-
changes in the insonated, proximal nor in the distal MCA-segments. Although changes in the 
proximal MCA diameter seem to contribute less to CBFV changes than do changes in the distal 
resistance vessels, a CBFV-increase measured at the proximal MCA segment might reflect not only 
an increased diameter in downstream resistance vessels, but also a decrease in the proximal MCA 
diameter [1, 10, 65-71]. 
Moreover, our results only show sympathetic effects on the phase angle between BP- and CBFV-
oscillations at frequencies between 0.04 and 0.15 Hz in response to dynamic BP changes occurring 
within seconds. Yet, the study cannot determine whether sympathetic activity also has a relevant 
effect on cerebral blood flow adjustment over an extended period of time, i.e. on CA under steady 
state conditions. 
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Figure captions 
Fig. 1 
Phase angle between sympathetically mediated LF-oscillations of blood pressure (BP) and 
cerebral blood flow velocity (CBFV) in 10 young, healthy volunteers before and during cold 
pressor stimulation (CPS) without and after oral intake of 25 mg carvedilol.  
Data are expressed in box plots. Without carvedilol, the phase angle was significantly smaller 
during than before CPS. This significant phase angle decrease upon CPS without carvedilol is 
indicated by an asterisk (*). The phase angle before CPS was similar with and without carvedilol. 
However, carvedilol increased (or widened) the phase angle during CPS (p<0.05), and the phase 
angle during CPS no longer differed from the phase angle before CPS (analysis of variance, post-
hoc t-tests). 
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Table 1 
Level of discomfort and cardiovascular parameters in 10 young, healthy volunteers before and 
during cold pressor stimulation without and after oral intake of 25 mg carvedilol.  
Parameter  before  
cold pressor 
stimulation 
during  
cold pressor 
stimulation 
t-test or 
Wilcoxon
-test 
level of discomfort without carvedilol        7.4 ± 1.3  
with carvedilol        6.9 ± 0.7  
RRI  
[ms] 
without carvedilol 1018.8 ± 164.8*   865.1 ± 162.9* p < 0.05 
with carvedilol 1110.9 ± 177.9* 1041.5 ± 185.4* p < 0.05 
BP  
[mmHg] 
without carvedilol      83.7 ± 7.3*     98.3 ± 11.3* p < 0.05 
with carvedilol      77.2 ± 6.7*     88.2 ± 11.1* p < 0.05 
CBFV  
[cm s-1] 
without carvedilol      55.3 ± 20.7*      62.6 ± 22.1* p < 0.05 
with carvedilol      46.7 ± 21.0*      51.8 ± 20.4* p < 0.05 
ETCO2 without carvedilol      35.1 ± 1.0      34.9 ± 1.4 p > 0.05 
[mmHg] with carvedilol      35.2 ± 1.6      34.9 ± 1.7 p > 0.05 
LF-powers of RRI 
[ms2] 
without carvedilol 1338.1 ± 1455.5* 2546.1 ± 2700.1* p < 0.05 
with carvedilol   489.1 ± 390.5*   948.9 ± 1055.9* p < 0.05 
HF-power of RRI 
[ms2] 
without carvedilol  1189.5 ± 1650.4  1257.9 ± 2196.1 p > 0.05 
with carvedilol  1287.9 ± 1383.1  1437.7 ± 2154.5 p > 0.05 
LF-power of BP 
[mmHg2] 
without carvedilol        4.0 ± 3.6*       7.4 ± 7.9* p < 0.05 
with carvedilol        2.3 ± 2.9*       3.3 ± 3.2* p < 0.05 
HF-power of BP 
[mmHg2] 
without carvedilol        0.4 ± 0.2        0.7 ± 0.7 p > 0.05 
with carvedilol        0.4 ± 0.2        0.6 ± 0.4 p > 0.05 
LF-power of CBFV 
[cm2 s-2] 
without carvedilol        5.2 ± 2.6*      11.7 ± 7.1* p < 0.05 
with carvedilol        3.3 ± 1.6*        5.8 ± 3.4* p < 0.05 
HF-power of CBFV 
[cm2 s-2] 
without carvedilol        1.5 ± 1.2         1.7 ± 1.0 p > 0.05 
with carvedilol        1.2 ± 0.6         1.7 ± 1.8 p > 0.05 
Phase shift 
[°] 
without carvedilol  -53.0 ± 20.1*     -34.3 ± 18.3* p < 0.05 
with carvedilol    -62.3 ± 26.1     -57.0 ± 23.8 p > 0.05 
Data are means ± SD. Significant differences in parameters at rest and during cold pressor stimulation are 
indicated by an asterisk (*). Significant differences in values recorded without partial sympathetic blockade 
and values recorded 2 hours after oral intake of 25 mg carvedilol are printed in bold. (RRI: RR-interval, BP: 
blood pressure, CBFV: cerebral blood flow velocity, ETCO2: end-tidal carbon dioxide level, LF: low-
frequency, HF: high-frequency) 
 27 
Fig. 1 
 
 
